Dexcom Overview
Dexcom Target Price
Analysts' 12-month price predictions for DXCM.
Get informed when a big investor buys or sells
+ FollowShare Price
$71.25
Average Target Price
$82.93
16.4% upside
16.4% upside14 analysts in the last 4 months
High: $100 | Low: $64
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-23 | Deutsche Bank | $86 | 20.7% upside |  |
| 2026-06-15 | Piper SandlerMatt O'Brien | $88 | 23.5% upside | |
| 2026-06-10 | UBS | $95 | 33.3% upside | |
| 2026-06-09 | Mizuho SecuritiesAnthony Petrone | $85 | 19.3% upside | |
| 2026-06-08 | Raymond James | $91 | 27.7% upside | |
| 2026-06-05 | Stifel NicolausJonathan Block | $90 | 26.3% upside | |
| 2026-05-18 | Canaccord Genuity | $82 | 15.1% upside | |
| 2026-05-18 | BarclaysMatt Miksic | $64 |  10.2% downside | |
| 2026-05-01 | Bernstein | $77 | 8.1% upside | |
| 2026-05-01 | Robert W. Baird | $80 | 12.3% upside | |
| 2026-05-01 | Mizuho SecuritiesAnthony Petrone | $75 | 5.3% upside | |
| 2026-05-01 | Raymond James | $81 | 13.7% upside | |
| 2026-05-01 | Canaccord Genuity | $100 | 40.4% upside | |
| 2026-05-01 | Barclays | $67 | 6% downside | |
| 2026-02-13 | Robert W. Baird | $87 | 22.1% upside | |
| 2026-02-13 | Mizuho SecuritiesAnthony Petrone | $90 | 26.3% upside | |
| 2026-02-13 | Canaccord Genuity | $95 | 33.3% upside | |
| 2026-02-13 | Barclays | $72 | 1.1% upside | |
| 2026-01-12 | Barclays | $71 | 0.4% downside | |
| 2026-01-09 | Bernstein | $86 | 20.7% upside | |
| 2025-12-17 | Mizuho Securities | $78 | 9.5% upside | |
| 2025-12-16 | Leerink PartnersMike Kratky | $92 | 29.1% upside | |
| 2025-12-02 | Morgan StanleyPatrick Wood | $75 | 5.3% upside | |
| 2025-11-10 | Morgan Stanley | $63 | 11.6% downside | |
| 2025-11-03 | BernsteinLee Hambright | $84 | 17.9% upside | |
| 2025-11-03 | Barclays | $80 | 12.3% upside | |
| 2025-10-31 | Piper SandlerMatt O'Brien | $75 | 5.3% upside | |
| 2025-10-31 | RBC Capital | $85 | 19.3% upside | |
| 2025-10-31 | Robert W. Baird | $82 | 15.1% upside | |
| 2025-10-31 | Wells Fargo | $93 | 30.5% upside | |
| 2025-10-31 | Canaccord GenuityWilliam Plovanic | $99 | 38.9% upside | |
| 2025-10-21 | Piper SandlerMatt O'Brien | $100 | 40.4% upside | |
| 2025-10-15 | Truist FinancialRichard Newitter | $94 | 31.9% upside | |
| 2025-09-26 | Robert W. Baird | $90 | 26.3% upside | |
| 2024-10-08 | RBC CapitalShagun Singh | $120 | 68.4% upside | |
| 2024-08-22 | Stifel NicolausMathew Blackman | $100 | 40.4% upside | |
| 2024-08-16 | RBC CapitalShagun Singh | $130 | 82.5% upside | |
| 2024-07-29 | BarclaysMatt Miksic | $113 | 58.6% upside | |
| 2024-07-26 | OppenheimerSteven Lichtman | $115 | 61.4% upside | |
| 2024-07-26 | Piper SandlerMatt O\'Brien | $90 | 26.3% upside | |
| 2024-07-26 | Canaccord GenuityWilliam Plovanic | $89 | 24.9% upside | |
| 2024-07-26 | RBC CapitalShagun Singh | $72.5 | 1.8% upside | |
| 2024-07-12 | Stifel NicolausMathew Blackman | $132 | 85.3% upside | |
| 2024-06-03 | OppenheimerSteven Lichtman | $150 | 110.5% upside | |
| 2024-05-30 | Redburn PartnersIssie Kirby | $130 | 82.5% upside | |
| 2024-03-12 | RBC CapitalShagun Singh | $165 | 131.6% upside | |
| 2023-10-27 | OppenheimerSteven Lichtman | $122 | 71.2% upside | |
| 2023-01-06 | Morgan Stanley | $131 | 83.9% upside | |
| 2022-12-26 | Stifel NicolausStifel Stifel | $130 | 82.5% upside | |
| 2022-12-12 | Citigroup | $146 | 104.9% upside | |